A 26 years old female had frequent episodes of focal left hand shaking followed by GTCS activity which would be most appropriate anti epileptic drug for this patient ? a) oxcarbazepine b) topiramate c) phenobarbitone d) valproate
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
The answer is confirmed. Here is the full analysis:
Answer: D) Valproate
Clinical Analysis
This patient has focal seizures (left hand shaking) with secondary generalization to GTCS - a classic presentation of focal epilepsy evolving to bilateral tonic-clonic seizures. The key challenge is selecting a drug that covers both the focal onset AND the generalized component.
Why Valproate is the Best Choice Here
Valproate is a broad-spectrum antiepileptic drug. According to Adams and Victor's Principles of Neurology, 12th Edition, valproate has multiple mechanisms of action (GABA potentiation, NMDA inhibition, sodium channel inhibition, T-type calcium channel inhibition) and its principal indications are "Focal and generalized seizures, absence seizures" - making it uniquely suited for mixed seizure types.
The Goldman-Cecil Medicine drug selection table confirms that for "focal seizures with or without evolution to bilateral tonic-clonic seizures", valproate is among the commonly used options with Class I evidence.
Why the Other Options Are Suboptimal
| Drug | Issue |
|---|---|
| A) Oxcarbazepine | Narrow-spectrum sodium channel blocker - indicated only for focal seizures. Does not adequately cover the generalized component. Could potentially worsen generalized epilepsy. |
| B) Topiramate | Broad-spectrum and effective, but carries significant cognitive side effects (mental slowing, word-finding difficulty) and is a second-line choice. Also teratogenic. |
| C) Phenobarbitone | Broad-spectrum but considered a third-line agent due to sedation, cognitive impairment, and enzyme induction. Not a preferred first-line drug in a young patient. |
| D) Valproate | Broad-spectrum, first-line, covers both focal onset and secondary generalized tonic-clonic seizures. Best answer. |
Important Caveat: Young Female Patient
The question involves a 26-year-old woman of childbearing age. Valproate carries well-established teratogenic risks (neural tube defects, lower IQ in children exposed in utero). In real clinical practice, this is a major concern and agents like lamotrigine or levetiracetam would often be preferred in women of childbearing potential. However, for the purpose of this pharmacology/exam question, valproate remains the textbook answer because:
- It is the only option listed that is broad-spectrum and covers both seizure types
- Among the four choices given, valproate has the best efficacy profile for this mixed focal + generalized presentation
- Oxcarbazepine (a narrow-spectrum drug) could actually worsen the generalized component
The correct answer is D) Valproate. (Adams and Victor's Principles of Neurology, 12th Ed., Table 15-5; Goldman-Cecil Medicine, Table 37-26)
This is a shared conversation. Sign in to Orris to start your own chat.